XML 34 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]
9 Months Ended
Sep. 30, 2020
Notes  
Liability for Future Policy Benefits and Unpaid Claims Disclosure

Note 10.Policy Benefits and Claims 

 

Policy benefits and claims is the liability for unpaid loss and loss adjustment expenses. It is comprised of unpaid claims and estimated incurred but not reported (“IBNR”) reserves related to the Company’s short-duration contracts. Summarized below are the changes in the total liability for policy benefits and claims for the periods indicated (in thousands). Amounts incurred below do not include expenses for policy benefits and costs incurred for the Company’s life, annuity and other long-duration contracts. In addition, certain loss adjustment expenses related to short-duration contracts that are included in amounts incurred below are classified as selling general and administrative expenses on the Condensed Consolidated Statements of Income.

 

 

 

Nine Months Ended September 30, 2020

 

 

Specialty

 

DBL and

 

Group

 

All Other

 

 

 

 

Health

 

PFL

 

Disability

 

Lines

 

Total

 

 

Balance at beginning of year

$

42,228  

$

23,438  

$

80,079  

$

19,057  

$

164,802  

Less: reinsurance recoverable

 

1,717  

 

664  

 

23,322  

 

11,290  

 

36,993  

Net balance at beginning of year

 

40,511  

 

22,774  

 

56,757  

 

7,767  

 

127,809  

 

 

 

 

 

 

 

 

 

 

 

Amount incurred, related to:

 

 

 

 

 

 

 

 

 

 

  Current year

 

67,352  

 

62,204  

 

26,865  

 

15,494  

 

171,915  

  Prior years

 

(4,009) 

 

(3,467) 

 

(2,998) 

 

(3,284) 

 

(13,758) 

 

 

 

 

 

 

 

 

 

 

 

  Total incurred

 

63,343  

 

58,737  

 

23,867  

 

12,210  

 

158,157  

 

 

 

 

 

 

 

 

 

 

 

Amount paid, related to:

 

 

 

 

 

 

 

 

 

 

  Current year

 

36,780  

 

31,040  

 

7,787  

 

9,227  

 

84,834  

  Prior years

 

25,554  

 

18,974  

 

15,630  

 

2,256  

 

62,414  

 

 

 

 

 

 

 

 

 

 

 

  Total paid

 

62,334  

 

50,014  

 

23,417  

 

11,483  

 

147,248  

 

 

 

 

 

 

 

 

 

 

 

Net balance at end of period

 

41,520  

 

31,497  

 

57,207  

 

8,494  

 

138,718  

Plus:  reinsurance recoverable

 

2,106  

 

595  

 

21,890  

 

10,805  

 

35,396  

Balance at end of period

$

43,626  

$

32,092  

$

79,097  

$

19,299  

$

174,114  

 

 

 

 

 

Nine Months Ended September 30, 2019

 

 

Specialty

 

DBL and

 

Group

 

All Other

 

 

 

 

Health

 

PFL

 

Disability

 

Lines

 

Total

 

 

Balance at beginning of year

$

38,363  

$

21,080  

$

82,222  

$

18,450  

$

160,115  

Less: reinsurance recoverable

 

1,335  

 

719  

 

24,712  

 

11,356  

 

38,122  

Net balance at beginning of year

 

37,028  

 

20,361  

 

57,510  

 

7,094  

 

121,993  

 

 

 

 

 

 

 

 

 

 

 

Amount incurred, related to:

 

 

 

 

 

 

 

 

 

 

  Current year

 

61,866  

 

48,594  

 

22,957  

 

12,521  

 

145,938  

  Prior years

 

(4,370) 

 

(6,424) 

 

(3,699) 

 

(1,457)  

 

(15,950) 

 

 

 

 

 

 

 

 

 

 

 

  Total incurred

 

57,496  

 

42,170  

 

19,258  

 

11,064  

 

129,988  

 

 

 

 

 

 

 

 

 

 

 

Amount paid, related to:

 

 

 

 

 

 

 

 

 

 

  Current year

 

32,806  

 

29,760  

 

6,852  

 

6,977  

 

76,395  

  Prior years

 

21,873  

 

13,772  

 

12,623  

 

3,058  

 

51,326  

 

 

 

 

 

 

 

 

 

 

 

  Total paid

 

54,679  

 

43,532  

 

19,475  

 

10,035  

 

127,721  

 

 

 

 

 

 

 

 

 

 

 

Net balance at end of period

 

39,845  

 

18,999  

 

57,293  

 

8,123  

 

124,260  

Plus:  reinsurance recoverable

 

1,837  

 

677  

 

23,712  

 

10,943  

 

37,169  

Balance at end of period

$

41,682  

$

19,676  

$

81,005  

$

19,066  

$

161,429  

 

Since unpaid loss and loss adjustment expenses are estimates, actual losses incurred may be more or less than the Company’s previously developed estimates and is referred to as either unfavorable or favorable development, respectively.

 

Net favorable (unfavorable) development in the Specialty Health segment, as depicted in the tables above, is comprised of the following lines of business for the period indicated (in thousands):

 

 

 

Nine Months Ended

 

 

September 30,

Specialty Health segment:

 

2020

 

2019

Short-term Medical

$

1,001  

$

471  

Occupational Accident

 

1,075  

 

1,921  

Limited Medical

 

349  

 

507  

Critical Illness

 

429  

 

269  

Group Gap

 

575  

 

98  

Fixed Indemnity Limited Benefit

 

(626) 

 

327  

Pet

 

646  

 

127  

All other specialty health lines

 

560  

 

650  

 

 

 

 

 

    Total Specialty Health segment

$

4,009  

$

4,370  

 

In 2020, net favorable development in the various lines of the Specialty Health segment shown above is primarily due to better than expected claim development. Unfavorable development in the Fixed Indemnity Limited Benefit line in 2020 is primarily due to higher than expected claim severity on a small number of policies. In 2019, favorable development in the occupational accident line, in run-off, is mainly due to some claims settling for amounts less than anticipated and due to a lower level of employer liability claims than anticipated in relation to historical levels. Net favorable development in the other lines of Specialty Health business in 2019 is primarily due to better than expected claim development.

 

In 2020, the net favorable development in the DBL and PFL business is mainly due to favorable premium refund reserve adjustments in the DBL line of business. In 2019, net favorable development is primarily due to favorable DBL claims experience.

 

In 2020, favorable development in the group disability business is primarily due to a reduction in the number of open claims and a reduction in the severity of new claims, specifically, new claims in the LTD line, partially offset by an increase in the overall frequency and severity of claims in the STD line. In 2019, favorable development in the group disability business is primarily due to better than expected claim development in terms of duration and net payments in the LTD business.

 

All other lines, primarily life and other individual health products and including our medical stop-loss business in run-off, experienced favorable development in 2020 and 2019 that is primarily related to the group term life business due to continued improvements in experience.

 

Included in the preceding rollforwards of the Company’s liability for policy benefits and claims are the policy benefits and claims activity associated with the Company’s health insurance lines. These are embedded within the Specialty Health segment. The table below summarizes the components of the change in the liability for policy benefits and claims that are specific to health insurance claims for the periods indicated (in thousands).

 

 

Specialty Health Segment

 

Health Insurance Claims

 

Nine Months Ended

 

September 30,

 

2020

 

 

2019

 

 

 

Balance at beginning of year

$

31,259  

 

$

26,068  

Less: reinsurance recoverable

 

1,113  

 

 

851  

Net balance at beginning of year

 

30,146  

 

 

25,217  

 

 

 

 

 

 

Amount incurred, related to:

 

 

 

 

 

  Current year

 

32,574  

 

 

38,950  

  Prior years

 

(2,292) 

 

 

(2,370) 

 

 

 

 

 

 

  Total incurred

 

30,282  

 

 

36,580  

 

 

 

 

 

 

Amount paid, related to:

 

 

 

 

 

  Current year

 

14,610  

 

 

15,630  

  Prior years

 

18,331  

 

 

15,357  

 

 

 

 

 

 

  Total paid

 

32,941  

 

 

30,987  

 

 

 

 

 

 

Net balance at end of period

 

27,487  

 

 

30,810  

Plus:  reinsurance recoverable

 

2,106  

 

 

919  

Balance at end of period

$

29,593  

 

$

31,729  

 

The $27,487,000 net balance of the Company’s health insurance claims liability at September 30, 2020 shown in the table above is all IBNR plus expected development on reported claims.